Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01334957 · ClinicalTrials.gov registry record · Phase 4
Surgical Surveillance Trial to Evaluate a Shortened Infusion Time of Intravenous Ibuprofen
A Phase 4 study, sponsored by Cumberland Pharmaceuticals.
- Completed
- Registry status
- Phase 4
- Development phase
- 300
- Enrollment target
NCT01334957 is a Phase 4 study that has completed, run by Cumberland Pharmaceuticals. The registered enrollment target is 300 participants.
The verdict
NCT01334957, a Phase 4 study, has completed, sponsored by Cumberland Pharmaceuticals.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 300 participants
- Enrollment target
Study Summary
The primary objective of this study is to determine the safety of a single dose of intravenous ibuprofen administered over 5-10 minutes for the preemptive treatment of postoperative pain.
Interventions
- DRUG Intravenous ibuprofen
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 300 participants |
| Start Date | 2011-06 |
| Est. Completion | 2013-01 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01334957
The ClinicalTrials.gov registry entry for NCT01334957 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 300 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Cumberland Pharmaceuticals, which has 43 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Intravenous ibuprofen is the first listed.
NCT01334957 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01334957 about?
NCT01334957 is a clinical study titled "Surgical Surveillance Trial to Evaluate a Shortened Infusion Time of Intravenous Ibuprofen". The primary objective of this study is to determine the safety of a single dose of intravenous ibuprofen administered over 5-10 minutes for the preemptive treatment of postoperative pain.
What is the current status of trial NCT01334957?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 300 participants. The study started on 2011-06. Estimated completion is 2013-01.
What interventions are being tested in trial NCT01334957?
The interventions under investigation include: Intravenous ibuprofen (DRUG).
Who is sponsoring clinical trial NCT01334957?
This trial is sponsored by Cumberland Pharmaceuticals, which has 43 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.